Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/21/2012CA2312975C Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
08/21/2012CA2288143C Activated protein c formulations
08/21/2012CA2251576C Glucagon-like peptide-2 analogs
08/16/2012WO2012109664A1 Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage
08/16/2012WO2012109646A1 Treatment of hcv in hiv infection patients
08/16/2012WO2012109561A2 Peptide compositions and methods for treating patients
08/16/2012WO2012109464A2 Modified peptide that reduces pain in peripheral neuropathy
08/16/2012WO2012109429A2 Lyophilized formulations
08/16/2012WO2012109387A1 Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
08/16/2012WO2012109373A2 Treatment of osteoarthritis and pain
08/16/2012WO2012109267A2 Novel peptides and methods using same
08/16/2012WO2012109167A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012WO2012108990A2 Peptide-phospholipid conjugates
08/16/2012WO2012108960A2 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
08/16/2012WO2012108828A1 Citrate free pharmaceutical compositions comprising anakinra
08/16/2012WO2012108827A1 Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity
08/16/2012WO2012108595A1 Proteinase-3 as a target for stroke treatment
08/16/2012WO2012108518A1 Bacteriocin derived from lactobacillus rhamnosus
08/16/2012WO2012108476A1 Method for producing radioactively labeled polypeptide
08/16/2012WO2012108410A1 Skin collagen production promoter
08/16/2012WO2012107932A1 B cell clonal immunotoxin and use thereof
08/16/2012WO2012107673A1 Use of creatine kinase for preventing or treating addiction to opiates
08/16/2012WO2012107592A1 Hexapeptide with improved activity in the repair of cellular dna of dermal cells
08/16/2012WO2012107567A2 Detection and removal of misfolded proteins/peptides
08/16/2012WO2012107493A1 Dual drug pen-injection device with micro-reservoirs carrying secondary drug for emergency injection
08/16/2012WO2012107364A1 Novel composition for the treatment of cystic fibrosis
08/16/2012WO2012107095A1 Plant hsp70 for use in the treatment of food allergy
08/16/2012WO2012107073A1 Ubiad1 for cellular coenzyme q10 synthesis and cardiovascular oxidative protection
08/16/2012WO2012106759A1 Modified plant defensins useful as anti-pathogenic agents
08/16/2012WO2012087943A3 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
08/16/2012WO2012087017A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
08/16/2012WO2012085165A4 Tear substitutes
08/16/2012WO2012084754A3 Pharmaceutical glp-1 compositions having an improved release profile
08/16/2012WO2012083078A3 Croos-linked peptides and proteins, methods of making same, and uses thereof
08/16/2012WO2012074676A3 Glp-1 agonists, dpp-4 inhibitors, compositions, and uses related thereto
08/16/2012WO2012071561A3 Anti-il-6 antibodies for the treatment of anemia
08/16/2012WO2012071554A3 Anti-il-6 antibodies for the treatment of oral mucositis
08/16/2012WO2012068236A3 Novel fungal oxidoreductases
08/16/2012WO2012061828A3 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
08/16/2012WO2012044675A3 Emulsion method for preparing low residual solvent microparticles
08/16/2012WO2012041761A3 Botulinum neurotoxin polypeptides exhibiting a prolonged activity
08/16/2012WO2012037519A3 Acceleration of wound healing by growth hormone releasing hormone and its agonists
08/16/2012WO2012037380A3 Formulations of guanylate cyclase c agonists and methods of use
08/16/2012WO2012029061A3 POLYPEPTIDES DERIVED FROM α-1 ANTITRYPSIN AND METHODS OF USE THEREOF
08/16/2012WO2012028965A3 Combination of semax and choline alfoscerate with antihypoxic neuroprotective, and antiαμνesic action and with ability to improve physical efficiency
08/16/2012WO2011134979A9 Stable aqueous mia/cd-rap formulations
08/16/2012WO2011094337A8 Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
08/16/2012WO2011091716A9 Epidermal growth factor receptor variant
08/16/2012WO2011005298A3 Enhancement of bmp retention
08/16/2012US20120208980 Process for solubilizing glucagon-like peptide 1 compounds
08/16/2012US20120208870 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/16/2012US20120208866 Intact minicells as vectors for dna transfer and gene therapy invitro and invivo
08/16/2012US20120208862 Rip140 regulation of glucose transport
08/16/2012US20120208784 Substituted propane phosphinic acid derivatives
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208773 Pharmaceutical compositions with tetrabenazine
08/16/2012US20120208772 Cytokine zalpha11 ligand
08/16/2012US20120208771 Synthetic cholesterylamine-linker derivatives for agent delivery into cells
08/16/2012US20120208770 Carcinoma Homing Peptide (CHP), Its Analogs, and Methods of Using
08/16/2012US20120208769 Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune Adjuvants
08/16/2012US20120208768 Specific binding sites in collagen for integrins and use thereof
08/16/2012US20120208767 Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
08/16/2012US20120208766 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120208765 Modified agrin-fragment capable of restoring muscle strength for use as a medicament
08/16/2012US20120208764 Method and compositions for treating stroke with fever
08/16/2012US20120208763 Nap alpha-aminoisobutyric acid analog with neuroprotective activity
08/16/2012US20120208762 Methods of Diagnosing Diastolic Dysfunction
08/16/2012US20120208761 Type i-type iv collagen hybrid gel
08/16/2012US20120208760 Thrombopoietic compounds
08/16/2012US20120208759 Long-acting coagulation factors and methods of producing same
08/16/2012US20120208758 Composition for the attachment of implants to collagen or other components of biological tissue
08/16/2012US20120208757 Use of hyaluronan for promoting angiogenesis
08/16/2012US20120208756 Composition for external preparation for skin
08/16/2012US20120208755 Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
08/16/2012US20120208754 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/16/2012US20120208753 Composition and Method for the Treatment or Prevention of Spinal Disorders III
08/16/2012US20120208752 Cell proliferation-promoting peptide and use thereof
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208750 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/16/2012US20120208749 Insulin derivatives
08/16/2012US20120208748 Peptide compositions and methods for treating patients
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012US20120208746 Genetic markers associated with response to cyclophilin-binding compounds
08/16/2012US20120208745 Treatment of hiv
08/16/2012US20120208744 Anti-microbial agents and compositions and methods of production and use thereof
08/16/2012US20120208743 Use of gelsolin to diagnose and treat inflammatory diseases
08/16/2012US20120208742 Compositions of a peptide targeting system for treating cancer
08/16/2012US20120208023 Bioactivation of particles
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207840 Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207820 Composition for treatment of multiple sclerosis
08/16/2012US20120207819 Compositions and methods for wound healing
08/16/2012US20120207813 Rapidly acting dry sealant and methods for use and manufacture
08/16/2012US20120207812 Skincare compositions comprising salicyclic acid
08/16/2012US20120207808 Devices and methods for treating defects in the tissue of a living being
08/16/2012US20120207796 Polymeric drug delivery compositions and methods for treating ophthalmic diseases
08/16/2012US20120207794 Water-soluble drug carrier and process for producing the same
08/16/2012US20120207789 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 3163